Guardion Launches Second Ocular Health Formula ‘GlaucoCetin’
04 juin 2019 07h00 HE
|
Guardion Health Sciences, Inc.
In an IRB-approved trial conducted at the New York Eye and Ear Infirmary, the parent compound of GlaucoCetin, GlaucoHealth, designed by Robert Ritch, MD, successfully reversed mitochondrial...